Interstitial lung disease
115 results
1 - 100
Interstitial lung disease
nintedanib- Pneumoconiosis
- Hyperventilation
- Idiopathic pulmonary fibrosis
- erlotinib
- Hypersensitivity pneumonitis
- Restrictive disease on PFTs
- Clubbed digits
- Pulmonary nodules (multiple)
- Scleroderma (systemic sclerosis)
- Diffusion capacity decreased on pulmonary function tests
Computed tomography (CT) - CHEST
Noncardiogenic Pulmonary Edema- Cardiomyopathy
- Wheezing
- Oxygen, partial pressure
- ado-trastuzumab
- Pneumothorax
- Dyspnea
- topotecan
- Respiratory alkalosis
- treprostinil
- Hypoxia and normal chest x-ray (CXR)
- Pneumothorax
- irinotecan liposomal
- palbociclib
- hydroxyurea
- riluzole
- Drug-induced lung disease
- Pulmonary hypertension
- datopotamab deruxtecan
A-a Oxygen Gradient - Cor Pulmonale
- fenofibric acid
- ceritinib
- sirolimus (topical)
- afatinib
- HIV & AIDS
- Acute respiratory failure
- lapatinib
- crizotinib
- fenofibrate
- trilaciclib
- capmatinib
- tepotinib
- Dermatomyositis/polymyositis
- panitumumab
- temsirolimus
- alectinib
- abemaciclib
- fam-trastuzumab deruxtecan
- Eosinophilic pulmonary syndromes
- Chronic cough
- leflunomide
- apalutamide
- gefitinib
- tocilizumab
- cabazitaxel
- binimetinib
- adagrasib
- irinotecan
- desvenlafaxine
- vandetanib
- ribociclib
- brigatinib
- dacomitinib
- lazertinib
- osimertinib
- ensartinib
- oxaliplatin
- anagrelide
- enfortumab vedotin
- amivantamab
- sirolimus (conventional)
- rifAMPin
- Pneumomediastinum
- mobocertinib
- PAZOPanib
- lorlatinib
- sirolimus (protein bound)
- cetuximab
- Pneumonia in immunocompromised host
- SORAfenib
- everolimus
- trametinib
- atezolizumab
- midostaurin
- carfilzomib
- brentuximab vedotin
- DOCEtaxel
- Scleroderma-associated antibody
- Ventilator Management